Drugs / AMG 691
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06637371 | Oct 2024 → Apr 2027 expected | asthma | Amgen | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 691 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06637371 ↗ |
| Route | Subcutaneous | “Subcutaneous (SC) injection” NCT06637371 ↗ |